Cite
HARVARD Citation
Domínguez, J. et al. (2023). Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet infectious diseases. 23 (4), pp. e122-e137. [Online].